GlassScriptPhysician profile
Steven L Giannotta
NPI 1114978871
$162,463.91
in general payments reported to CMS, 2019-2025
7 companies · $28K in 2025
The $28K reported for 2025 was more than what 92% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $18K · 2021: $21K · 2022: $26K · 2023: $22K · 2024: $25K · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $71K · Honoraria: $3,575 · Food and Beverage: $593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $71,155.38 |
| Honoraria | $3,574.89 |
| Food and Beverage | $592.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $121,815.09 | 2019-2025 | Integra, Budde, Integra Duo |
| Mizuho America, INC. | $39,914.16 | 2019-2024 | |
| Carl Zeiss Meditec USA, INC. | $215.57 | 2025 | |
| Zap Surgical Systems, INC. | $171.79 | 2023 | Zap-X Radiosurgery System, Zap-X Treatment Planning Software, Zap-X Treatment Delivery Software |
| Medtronic, INC. | $165.03 | 2024-2025 | Anteralign Spinal System With Titan Nanolock Surface Technology, Mazor X System |
| Leica Microsystems INC. | $141.96 | 2021 | |
| Stryker Corporation | $40.31 | 2023 | Adherus Autospray Et Dural Sealant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Giannotta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.